Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.26 USD | -5.97% | -4.55% | +7.69% |
Apr. 16 | Clearside Biomedical, Inc Appoints Anthony S. Gibney to its Board of Directors | CI |
Mar. 18 | Clearside Biomedical Names Victor Chong Chief Medical Officer | MT |
Financials (USD)
Sales 2024 * | 2.74M | Sales 2025 * | 7.36M | Capitalization | 94.15M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -43M | EV / Sales 2024 * | 26.6 x |
Net cash position 2024 * | 21.26M | Net Debt 2025 * | 12.33M | EV / Sales 2025 * | 14.5 x |
P/E ratio 2024 * |
-2.4
x | P/E ratio 2025 * |
-2.17
x | Employees | 30 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.7% |
Latest transcript on Clearside Biomedical, Inc.
1 day | -5.97% | ||
1 week | -4.55% | ||
Current month | -17.65% | ||
1 month | -27.17% | ||
3 months | +4.13% | ||
6 months | +75.51% | ||
Current year | +7.69% |
Managers | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Charles Deignan
DFI | Director of Finance/CFO | 59 | 11-12-31 |
Susan L. Coultas
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Jeffrey Edwards
BRD | Director/Board Member | 64 | 18-09-25 |
Christy Shaffer
BRD | Director/Board Member | 66 | 11-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.26 | -5.97% | 135,399 |
24-04-24 | 1.34 | -2.19% | 201,427 |
24-04-23 | 1.37 | -2.84% | 232,166 |
24-04-22 | 1.41 | +7.63% | 299,484 |
24-04-19 | 1.31 | -0.76% | 228,503 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.69% | 94.15M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- CLSD Stock